1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Circulating Tumor Cell: new trials by email Literature Review of Circulating Tumor Cell trials Research Report on Circulating Tumor Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs) Cabazitaxel, Antihistamine, Corticosteroid - Circulating Tumor Cell, Metastatic Prostate Cancer | Phase 2 | Unknown | Erasmus Medical Center | 140 | 2017-02-21 | 2021-08-20 |
Bulbo-Spinal Atrophy, X-Linked (1) · Neoplastic Cells, Circulating (1) · Prostatic Neoplasms (1)
Central Nervous System Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Heredodegenerative Disorders, Nervous System (1) · Male Urogenital Diseases (1) · Motor Neuron Disease (1) · Muscular Atrophy, Spinal (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplastic Processes (1)
Adrenal Cortex Hormones (1) · Antiemetics (1) · Histamine Antagonists (1) · Histamine H2 Antagonists (1) · cabazitaxel (1)
Netherlands (1)